|
OMIM |
Link |
Information gain |
01 |
|
complement component 5 deficiency
|
[NCBI]
|
0.00092096
|
|
|
C5
|
[NCBI]
|
0.000563428
|
|
|
ARMD9
|
[NCBI]
|
0.000141743
|
|
|
antiphospholipid syndrome
|
[NCBI]
|
9.93428e-05
|
|
|
C3
|
[NCBI]
|
7.55427e-05
|
|
|
C5R1
|
[NCBI]
|
6.30357e-05
|
|
|
MCP
|
[NCBI]
|
5.72139e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
5.6299e-05
|
|
|
SLE
|
[NCBI]
|
5.53872e-05
|
|
|
MPO
|
[NCBI]
|
5.07833e-05
|
|
|
C4B
|
[NCBI]
|
4.82092e-05
|
|
|
RA
|
[NCBI]
|
3.90195e-05
|
|
|
VSIG4
|
[NCBI]
|
3.30038e-05
|
|
|
complement component 8 deficiency, type ii
|
[NCBI]
|
3.0264e-05
|
|
|
TRAF1
|
[NCBI]
|
2.89985e-05
|
|
|
CFD
|
[NCBI]
|
2.79764e-05
|
|
|
MBL2
|
[NCBI]
|
2.71419e-05
|
|
|
BCHE
|
[NCBI]
|
2.68509e-05
|
|
|
C7
|
[NCBI]
|
2.57327e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
2.2113e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
2.10035e-05
|
|
|
C4A
|
[NCBI]
|
2.01934e-05
|
|
|
CLU
|
[NCBI]
|
1.66072e-05
|
|
|
CFH
|
[NCBI]
|
1.52393e-05
|
|
|
HP
|
[NCBI]
|
7.78802e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
7.6654e-06
|
|
|
IL2
|
[NCBI]
|
7.15272e-06
|
|
|
MG
|
[NCBI]
|
2.68893e-06
|
|
|
TNF
|
[NCBI]
|
1.39731e-06
|
|
|
VEGF
|
[NCBI]
|
1.22909e-06
|
|
|
CF
|
[NCBI]
|
1.12729e-06
|
|
|
TH
|
[NCBI]
|
2.99726e-07
|
|
|
AD
|
[NCBI]
|
2.52852e-07
|
|
|
NGFB
|
[NCBI]
|
2.78792e-08
|
|